DKK410.10
0.51% day before yesterday
Copenhagen, Dec 27, 05:00 pm CET
ISIN
DK0060336014
Symbol
NSIS B
Industry

Novonesis Stock price

DKK410.10
-4.30 1.04% 1M
-21.60 5.00% 6M
+39.00 10.51% YTD
+38.20 10.27% 1Y
-117.10 22.21% 3Y
+80.10 24.27% 5Y
+150.20 57.79% 10Y
Copenhagen, Closing price Fri, Dec 27 2024
+2.10 0.51%
ISIN
DK0060336014
Symbol
NSIS B
Industry

Key metrics

Market capitalization DKK190.54b
Enterprise Value DKK197.54b
P/E (TTM) P/E ratio 37.58
EV/FCF (TTM) EV/FCF 86.07
EV/Sales (TTM) EV/Sales 11.04
P/S ratio (TTM) P/S ratio 10.65
P/B ratio (TTM) P/B ratio 8.14
Dividend yield 1.46%
Last dividend (FY22) DKK6.00
Revenue growth (TTM) Revenue growth 1.97%
Revenue (TTM) Revenue DKK17.90b
EBIT (operating result TTM) EBIT DKK4.45b
Free Cash Flow (TTM) Free Cash Flow DKK2.30b
Cash position DKK1.16b
EPS (TTM) EPS DKK10.91
P/E forward 72.92
P/S forward 6.46
EV/Sales forward 6.70
Show more

Is Novonesis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Novonesis Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Novonesis forecast:

12x Buy
63%
5x Hold
26%
2x Sell
11%

Analyst Opinions

19 Analysts have issued a Novonesis forecast:

Buy
63%
Hold
26%
Sell
11%

Financial data from Novonesis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '23
+/-
%
17,899 17,899
2% 2%
100%
- Direct Costs 8,113 8,113
2% 2%
45%
9,786 9,786
2% 2%
55%
- Selling and Administrative Expenses 1,935 1,935
9% 9%
11%
- Research and Development Expense 2,017 2,017
1% 1%
11%
5,834 5,834
0% 0%
33%
- Depreciation and Amortization 1,389 1,389
6% 6%
8%
EBIT (Operating Income) EBIT 4,445 4,445
3% 3%
25%
Net Profit 3,024 3,024
18% 18%
17%

In millions DKK.

Don't miss a Thing! We will send you all news about Novonesis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Head office Denmark
CEO Ester Baiget
Employees 6,756
Website www.novonesis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today